Subscribe to thousands of academic journals for just $40/month
Read and share the articles you need for your research, all in one place.

Furazolidone disposition after intravascular and oral dosing in the channel catfish

Xenobiotica , Volume 24 (11) – Jan 1, 1994


Informa UK Ltd
© 1994 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted
Original Article
Publisher site
See Article on Publisher Site

Preview Only

Expand Tray Hide Tray

Furazolidone disposition after intravascular and oral dosing in the channel catfish


1. The pharmacokinetics, tissue distribution and excretion of the nitrofuran drug furazolidone have been examined in the channel catfish. ( 14 C)Furazolidone was administered by intravascular or oral routes in a single dosage of 1 mg/kg body weight. 2. A two-compartment pharmacokinetic model best described parent furazolidone concentrations in the plasma after intravascular dosing. Elimination of parent compound was extremely rapid, with a terminal half-life of 0·27h and total body clearance of 1901ml/h/kg. 3. After oral dosing, furazolidone concentrations in the plasma were highest at 1 h and were below the limit of determination (< 20 ng/ml) at 5 h. The oral bioavailability of parent furazolidone administered in solution was 58%, compared with 28% in a feed mixture. 4. Concentrations of furazolidone and its metabolites were highest in the excretory tissues and lowest in the muscle after oral dosing. Parent furazolidone comprised 10% of the total 14 C in the muscle at 8h and was not detectable (<1 ng/g) at 24h; total 14 C concentrations declined from 274 to 59 ng furazolidone equiv./g between 8 and 168h. Non-extractable (bound) residues comprised 18% of total 14 C in muscle at 8h and 33% at 168h. 5. Renal excretion was the primary route of elimination of 14 C residues and accounted for nearly 55% of the oral dose.
Loading next page...

Preview Only. This article cannot be rented because we do not currently have permission from the publisher.